145 related articles for article (PubMed ID: 36150583)
1. Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial.
Jung RG; Di Santo P; Mathew R; Simard T; Parlow S; Weng W; Abdel-Razek O; Malhotra N; Cheung M; Hutson JH; Marbach JA; Motazedian P; Thibert MJ; Fernando SM; Nery PB; Nair GM; Russo JJ; Hibbert B; Ramirez FD
Can J Cardiol; 2023 Apr; 39(4):394-402. PubMed ID: 36150583
[TBL] [Abstract][Full Text] [Related]
2. No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trial.
Prosperi-Porta G; Motazedian P; Di Santo P; Jung RG; Parlow S; Abdel-Razek O; Simard T; Hutson J; Malhotra N; Fu A; Ramirez FD; Froeschl M; Mathew R; Hibbert B;
J Cardiol; 2022 Oct; 80(4):358-364. PubMed ID: 35725945
[TBL] [Abstract][Full Text] [Related]
3. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Mathew R; Di Santo P; Jung RG; Marbach JA; Hutson J; Simard T; Ramirez FD; Harnett DT; Merdad A; Almufleh A; Weng W; Abdel-Razek O; Fernando SM; Kyeremanteng K; Bernick J; Wells GA; Chan V; Froeschl M; Labinaz M; Le May MR; Russo JJ; Hibbert B
N Engl J Med; 2021 Aug; 385(6):516-525. PubMed ID: 34347952
[TBL] [Abstract][Full Text] [Related]
4. The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.
Parlow S; Di Santo P; Mathew R; Jung RG; Simard T; Gillmore T; Mao B; Abdel-Razek O; Ramirez FD; Marbach JA; Dick A; Glover C; Russo JJ; Froeschl M; Labinaz M; Fernando SM; Hibbert B;
Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):712-720. PubMed ID: 34382063
[TBL] [Abstract][Full Text] [Related]
5. Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.
Di Santo P; Mathew R; Jung RG; Simard T; Skanes S; Mao B; Ramirez FD; Marbach JA; Abdel-Razek O; Motazedian P; Parlow S; Boczar KE; D'Egidio G; Hawken S; Bernick J; Wells GA; Dick A; So DY; Glover C; Russo JJ; McGuinty C; Hibbert B;
Crit Care; 2021 Aug; 25(1):289. PubMed ID: 34376218
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
[TBL] [Abstract][Full Text] [Related]
7. Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock.
Jung RG; Di Santo P; Mathew R; Abdel-Razek O; Parlow S; Simard T; Marbach JA; Gillmore T; Mao B; Bernick J; Theriault-Lauzier P; Fu A; Lau L; Motazedian P; Russo JJ; Labinaz M; Hibbert B
J Am Heart Assoc; 2021 Nov; 10(21):e021570. PubMed ID: 34713704
[TBL] [Abstract][Full Text] [Related]
8. Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
Rodenas-Alesina E; Luis Scolari F; Wang VN; Brahmbhatt DH; Mihajlovic V; Fung NL; Otsuki M; Billia F; Overgaard CB; Luk A
ESC Heart Fail; 2023 Aug; 10(4):2577-2587. PubMed ID: 37322827
[TBL] [Abstract][Full Text] [Related]
9. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
[TBL] [Abstract][Full Text] [Related]
10. Milrinone vs Dobutamine for the Management of Cardiogenic Shock: Implications of Renal Function and Injury.
Di Santo P; Dehghan K; Mao B; Jung RG; Fadare D; Paydar J; Parlow S; Motazedian P; Prosperi-Porta G; Abdel-Razek O; Joseph J; Goh CY; Chung K; Mulloy A; Ramirez FD; Simard T; Hibbert B; Mathew R; Russo JJ
JACC Adv; 2023 Jul; 2(5):100393. PubMed ID: 38938997
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis.
Mathew R; Visintini SM; Ramirez FD; DiSanto P; Simard T; Labinaz M; Hibbert BM
Clin Invest Med; 2019 Jun; 42(2):E26-32. PubMed ID: 31228965
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J
J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599
[TBL] [Abstract][Full Text] [Related]
13. Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial.
Marbach JA; Di Santo P; Kapur NK; Thayer KL; Simard T; Jung RG; Parlow S; Abdel-Razek O; Fernando SM; Labinaz M; Froeschl M; Mathew R; Hibbert B
J Am Heart Assoc; 2022 Mar; 11(6):e023322. PubMed ID: 35261289
[TBL] [Abstract][Full Text] [Related]
14. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
Hu K; Mathew R
Curr Opin Crit Care; 2022 Aug; 28(4):419-425. PubMed ID: 35792520
[TBL] [Abstract][Full Text] [Related]
15. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
16. Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI Trial.
Parlow S; Weng W; Di Santo P; Jung RG; Lepage-Ratte MF; Motazedian P; Prosperi-Porta G; Abdel-Razek O; Simard T; Chan V; Labinaz M; Froeschl M; Mathew R; Hibbert B;
Can J Cardiol; 2022 Aug; 38(8):1211-1219. PubMed ID: 35430192
[TBL] [Abstract][Full Text] [Related]
17. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
King JB; Shah RU; Sainski-Nguyen A; Biskupiak J; Munger MA; Bress AP
Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic and proarrhythmic effects of intravenous inotropic agents.
Tisdale JE; Patel R; Webb CR; Borzak S; Zarowitz BJ
Prog Cardiovasc Dis; 1995; 38(2):167-80. PubMed ID: 7568905
[TBL] [Abstract][Full Text] [Related]
19. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
[TBL] [Abstract][Full Text] [Related]
20. Inotropic therapy for right ventricular failure in newborn piglets: effect on contractility, hemodynamics, and interventricular interaction.
Hyldebrandt JA; Frederiksen CA; Heiberg J; Rothmann S; Redington AN; Schmidt MR; Ravn HB
Pediatr Crit Care Med; 2014 Sep; 15(7):e327-33. PubMed ID: 25080150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
